4531 - 4540 of 9156 Results
Title
Year
- Multidimensional nonadditivity in one-facet g-theory designs: A profile analytic approach.2022RESTRICTEDTitle: Multidimensional nonadditivity in one-facet g-theory designs: A profile analytic approach.Journal Name: Psychological MethodsPublisher: American Psychological Association (APA)Vol: 28Issue #: 3Start Page: 651End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/met0000452Citation Count: 2
-
OPENTitle: Longitudinal study investigating the influence of COMT gene polymorphism on cortical thickness changes in Parkinson's disease over four yearsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 9920End Page: 9920Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-60828-7Best OA location URL: https://doi.org/10.1038/s41598-024-60828-7Citation Count: 1
-
OPENTitle: Early Detection of Parkinson’s Disease by Using SPECT Imaging and BiomarkersJournal Name: Journal of Intelligent SystemsPublisher: Walter de Gruyter GmbHVol: 29Issue #: 1Start Page: 1329End Page: 1344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/jisys-2018-0261Best OA location URL: https://www.degruyter.com/downloadpdf/journals/jisys/29/1/article-p1329.pdfCitation Count: 28
-
OPENTitle: Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 TrialsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1663End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212672Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212672?id=journal-of-parkinsons-disease%2Fjpd212672Citation Count: 42
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 61
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 89
-
OPENTitle: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 19Start Page: 1944End Page: 1950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9aBest OA location URL: https://n.neurology.org/content/neurology/79/19/1944.full.pdfCitation Count: 155
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 1
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://hdl.handle.net/2027.42/137619Citation Count: 98
- A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease2018OPENTitle: A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 1Start Page: 117End Page: 129Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25274Citation Count: 67